Esther San Roman Rodriguez

Local production of lactate, ribose phosphate, and amino acids within human triple-negative breast cancer.

J. Rabinowitz, D. V. Von Hoff, V. Espina, 2021, Med.

Pilot clinical trial and phenotypic analysis in chemotherapy-pretreated, metastatic triple-negative breast cancer patients treated with oral TAK-228 and TAK-117 (PIKTOR) to increase DNA damage repair deficiency followed by cisplatin and nab paclitaxel

V. Zismann, V. Espina, J. O’Shaughnessy, 2023, Biomarker Research.

Targeting HER2 / HER3 co‐mutations in metastatic breast cancer: Case reports of exceptional responders to trastuzumab and pertuzumab therapy

M. Pierobon, M. Levin, Esther San Roman Rodriguez, 2024, Cancer reports.